https://pubmed.ncbi.nlm.nih.gov/11438309/
Prucalopride is a novel enterokinetic compound and is the first representative of the benzofuran class. We set out to establish its pharmacological profile in...
vitropharmacologicalprofileprucalopridenovel
https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/u-s-fda-accepts-new-drug-application-prucalopride-chronic-idiopathic-constipation/
Shire (NASDAQ: SHPG) announces that the U.S. Food and Drug Administration (FDA) has accepted the submission of a New Drug Application (NDA) for prucalopride...
new drug applicationfdaacceptsprucalopride